Sirolimus allows calcineurin-inhibitor withdrawal in heart transplant patients with renal impairment resulting in improved renal function.

被引：0
|
作者：
Zolty, R [1 ]
Keller, KE [1 ]
Ireland, NP [1 ]
Frisk, RL [1 ]
Stepien, LD [1 ]
Lowes, BD [1 ]
Shakar, S [1 ]
Wolfel, EE [1 ]
Lindenfeld, J [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
67
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [11] Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus
    Teutonico, A
    Schena, PF
    Di Paolo, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (10): : 3128 - 3135
  • [12] RENAL FUNCTION, EFFICACY AND SAFETY OF SIROLIMUS AND MYCOPHENOLAT MOFETIL THERAPY AFTER EARLY CALCINEURIN-INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: ONE-YEAR ANALYSIS OF A RANDOMIZED MULTICENTER TRIAL
    Guba, Markus
    Pratschke, Johann
    Hugo, Christian
    Kraemer, Bernhard
    Nohr-Westphal, Constanze
    Brockmann, Jens
    Jauch, Karl-Walter
    TRANSPLANT INTERNATIONAL, 2009, 22 : 78 - 78
  • [13] Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Backman, L
    Reisæter, AV
    Wramner, L
    Ericzon, BG
    Salmela, K
    Brattström, C
    CLINICAL TRANSPLANTATION, 2006, 20 (03) : 336 - 339
  • [14] IMPROVEMENT IN GLUCOSE REGULATION AND VASCULAR FUNCTION IN RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN-INHIBITOR TO SIROLIMUS-BASED IMMUNOSUPPRESSION
    Messineo, A.
    Viecelli, A.
    Chan, D.
    Dogra, G.
    Lim, W.
    NEPHROLOGY, 2010, 15 : 60 - 61
  • [15] Mechanisms of improvement in renal function after conversion to sirolimus (SRL) from a calcineurin-inhibitor (CI) regimen in patients with chronic transplant nephropathy (CTN).
    Barakat, IB
    Zayas, CF
    Guasch, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 365A - 365A
  • [16] Calcineurin-Inhibitor Minimization in Liver Transplant Patients with Calcineurin-Inhibitor-Related Renal Dysfunction: A Meta-Analysis
    Kong, Yuan
    Wang, Dongping
    Shang, Yushu
    Liang, Wenhua
    Ling, Xiaoting
    Guo, Zhiyong
    He, Xiaoshun
    PLOS ONE, 2011, 6 (09):
  • [17] Calcineurin-Inhibitor Free Sirolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients
    Rossano, Joseph W.
    Ryan, Rachel M.
    Orfanelli, Laura
    McCandless, Karen V.
    Kaufman, Beth D.
    Lin, Kimberly Y.
    Paridon, Stephen M.
    Hanna, Brian D.
    Shaddy, Robert E.
    CIRCULATION, 2012, 126 (21)
  • [18] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients
    Budde, K.
    Zeier, M.
    Haller, H.
    Arns, W.
    Kramer, S.
    Vogel, E. M.
    Pietruck, F.
    Reinke, P.
    Rath, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 504 - 504
  • [19] Calcineurin inhibitor withdrawal in renal transplant recipients: Improvement in renal function and reduction of cardiovascular risk.
    Mazzali, M
    Quadros, KRS
    Santos, RLS
    Alves, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 650A - 650A
  • [20] Improvement of renal function in transplant patients with chronic calcineurin-inhibitor (CNI) nephrotoxicity one year after conversion to Sirolimus (SRL): Predictive value of proteinuria.
    Diekmann, F
    Budde, K
    Oppenheimer, F
    Fritsche, L
    Neumayer, HH
    Campistol, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 648A - 648A
12345